Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
Joachim Diessner(University of Würzburg), Jörg Wischhusen(Universitätsklinikum Würzburg)
Cited by 60
Related Papers
GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas
|Clinical Cancer Research|2010|174
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment
|Nature Communications|2023|89